Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
about
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alphaLRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stressThe role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatmentSelective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's diseaseEvaluation of Models of Parkinson's DiseaseThe interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesiasActivin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's diseaseMagnetic resonance imaging (MRI) to study striatal iron accumulation in a rat model of Parkinson's diseaseParkinson's disease: animal models and dopaminergic cell vulnerabilityDose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout miceGene-environment interactions: key to unraveling the mystery of Parkinson's diseaseEnvironmental modulations of the number of midbrain dopamine neurons in adult miceSuppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallinGDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse modelCHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonismLocus ceruleus and anterior cingulate cortex sustain wakefulness in a novel environmentDyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeysDelayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease.Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways.An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons.Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences.Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's diseaseBrain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson diseaseMidbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.Neuronal Entropy Depends on the Level of Alertness in the Parkinsonian Globus Pallidus in vivoThe Wld(S) mutation delays anterograde, but not retrograde, axonal degeneration of the dopaminergic nigro-striatal pathway in vivo.Toxin-induced models of Parkinson's disease.The Treadmill Exercise Protects against Dopaminergic Neuron Loss and Brain Oxidative Stress in Parkinsonian Rats.Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo.The analysis of differential induction of hsp70 in the related cerebral domains and nerve fibers of rats after proteasome inhibiton.Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseasesNeurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease.Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculatureProtective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease.Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's diseaseRutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease.
P2860
Q23916369-15ABEA60-61F2-4081-AC57-96ED302A69D8Q24294466-A648988D-4DCE-4386-97F2-889240C15411Q24675617-B8CE52F8-85B9-49DE-AFE6-FA6D62D4F1DBQ24794457-E05EB11F-D1AA-4185-90BB-63178D713D52Q26772843-5C16D35B-39A8-4C1F-950A-D0F9AC7251BBQ26826951-EDC29136-1769-472F-AB0F-DE12EF5F637BQ27309140-57E7864D-B1F0-4A11-8EA9-759F6377F166Q27325407-3B3A5FA9-697A-427F-BC3D-3609DD3DC715Q28080503-99C564AC-0172-4185-BEF7-D37E13CCBFFFQ28363006-DD0244B3-9CC8-4A8D-9137-30CE1FC39244Q28388674-932C9E4D-E152-462E-9162-C861BBBABD4AQ28468524-67340D59-A337-4BA1-A326-36D42D6DE514Q28510018-7DFEBC1F-DD6B-46B8-BEEC-5235EAE017EDQ28543023-2D9FB452-5E1F-4FEF-84E9-85FBBE071C42Q28579022-8C1DF6DD-FA8F-4A9A-8C9A-46B1E3CCD2BCQ28581853-A798AEA6-7FED-44E3-8997-483219B0A98AQ30498440-9EE5E271-B337-460F-9A10-ED3F21557B97Q30666545-C54C8E45-3AD6-4336-9CE8-14329E994D0BQ32160990-8D7E531E-32EB-4BCE-BA87-6E7528160BCFQ33292773-37B1F5C2-B2EA-4349-A4B5-3A99F5166CF2Q33502757-67209198-E971-4E45-B3D3-37CCB5047251Q33599017-B1AE69CC-EE30-478F-9BF5-FB3DDF8D646EQ33658107-D62CF14D-910D-465C-A418-9280A7618CD6Q33718730-3350A5A2-23B9-4360-800A-AB520CAD6D3CQ33745707-AD70EF0D-2187-4329-82A2-4C2349D23BF3Q33801793-1BC3DF4E-FAF4-42E7-BCF6-6DD579DEE296Q33841702-F6E17424-722B-4584-9D11-E153526AC98AQ33844749-A0B7C567-41DD-4CA8-930B-931B4074F02CQ33872721-7F9B0DA7-6583-467D-BDBD-363C7CD3AA9EQ33939425-A6D972A0-7C7D-4010-856E-89CA4573F012Q33960102-418A36B5-0F5A-4EA6-A52D-897A8D00EA70Q33979521-CFEDDC08-5459-4EF7-B93C-4F9AF8EAC2EEQ34063565-B52CE0DE-8F8F-47D3-88AE-00953729001BQ34108184-E0B86A01-E0F0-4407-B869-8780D344D9A0Q34189618-6D1A8CEB-A7A7-491A-B375-02387105EC55Q34237258-FBC3AD88-4BFB-4257-8709-753DF2889FA6Q34269340-C93D125B-59AF-4D5A-9432-3863CEDB3A60Q34345872-66D49DDC-BE98-4801-A0C4-A60AB7808111Q34473323-8FDC6A36-E542-45C6-819A-E8B7CACE7644Q34634606-055112D9-6D0E-4209-8EAE-5BDB056813D5
P2860
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Progressive degeneration of ni ...... cytochemical study in the rat.
@en
Progressive degeneration of ni ...... cytochemical study in the rat.
@nl
type
label
Progressive degeneration of ni ...... cytochemical study in the rat.
@en
Progressive degeneration of ni ...... cytochemical study in the rat.
@nl
prefLabel
Progressive degeneration of ni ...... cytochemical study in the rat.
@en
Progressive degeneration of ni ...... cytochemical study in the rat.
@nl
P1433
P1476
Progressive degeneration of ni ...... cytochemical study in the rat.
@en
P2093
P304
P356
10.1016/0306-4522(94)90605-X
P407
P577
1994-03-01T00:00:00Z